Related Experiment Video
Updated: Apr 5, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
11.0K
Regulatory aspects on nanomedicines.
Vanessa Sainz1, João Conniot1, Ana I Matos1
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
Biochemical and Biophysical Research Communications
|August 12, 2015
Summary
Nanomedicines offer advanced therapeutic solutions but require thorough characterization to ensure patient safety. Regulatory science is crucial for the efficient and safe translation of these innovative nanomedicines into clinical practice.
Area of Science:
- Pharmaceutical research
- Biomaterials science
- Nanotechnology
Background:
- Nanomedicines represent a significant advancement in pharmaceutical research, addressing unmet medical needs.
- Advances in biomaterials and nanotechnology enable nanomedicines to overcome limitations of conventional therapies, such as non-specific effects.
- The broad applications of nanomedicines necessitate a deep understanding of their properties to prevent adverse events like immune reactivity.
Purpose of the Study:
- To review key regulatory aspects for nanomedicines.
- To discuss industry and regulatory agency efforts in advancing nanomedicine translation.
- To highlight the role of regulatory science in accelerating safe nanomedicine development.
Main Methods:
- Review of current regulatory science challenges and strategies for nanomedicines.
- Analysis of collaborative efforts between researchers, industry, and regulatory bodies.
- Discussion of translational requirements for clinical development.
Main Results:
- The development of nanomedicines faces challenges requiring new scientific and technological tools.
- Collaboration among stakeholders, including patients, is increasing.
- Proactive regulatory policies and integrated research tools are essential for future development.
Conclusions:
- Understanding and characterizing nanomedicines is critical for safe clinical application.
- Regulatory science plays a pivotal role in facilitating the faster and safer development of nanomedicines.
- Continued collaboration and proactive regulatory strategies are key to successfully translating nanomedicine innovations to the market.
Related Concept Videos
01:25Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
659
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
659
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
72
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
72
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
478
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
478
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
353
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
353